Navigation Links
Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC 'Targets' Conference
Date:10/18/2007

BERKELEY HEIGHTS, N.J., Oct. 18 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) announced that new clinical and preclinical data on Genasense(R) (oblimersen sodium) Injection, its lead anticancer compound, will be presented at the "Molecular Targets and Therapeutics" conference that will take place from October 22-26, 2007 in San Francisco, CA. The "Targets" meeting is jointly sponsored by the U.S. National Cancer Institute (NCI), the American Association for Cancer Research (AACR), and the European Organization for the Research and Treatment of Cancer (EORTC).

Titles and dates of the presentations include the following:

#A180: Bcl-2 antisense oligodeoxynucleotides and GSH depletion-induced sensitization to chemotherapy lead to complete regression of A375 melanoma xenografts. Presenter: S. Menal, University of Valencia. October 23, 2007.

#A166: Phase 1 pharmacokinetic and pharmacodynamic study of oblimersen (Genasense) administered as a weekly 2-hr intravenous infusion. Presenter: A. Tolcher, South Texas Accelerated Research Therapeutics, San Antonio, TX. October 23, 2007.

About Genasense

Genasense inhibits production of Bcl-2, a protein made by cancer cells that is thought to block chemotherapy-induced apoptosis (programmed cell death). By reducing the amount of Bcl-2 in cancer cells, Genasense may enhance the effectiveness of current anticancer treatment. Genta is pursuing a broad clinical development program with Genasense evaluating its potential to treat various forms of cancer.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2008)...RNewswire-USNewswire/ -- MedImmune announced today...ademy of Pediatrics (AAP),2008 National Conference...dy of research into the prevention of respiratory ...spiratory infection among preterm infants., "As w... RSV disease on,preterm babies, the benefits of pr...
(Date:10/10/2008)...., Oct. 10 /- Neurobiologic...oday announced it will hold a,conference call on M...rinex(TM) (ancrod) Phase 3 Trial Program for acute... Freiman, president and chief executive,officer an...-- Date: Monday, October 13, 2008 -- Time: 1:00 ...
(Date:10/10/2008)...exas, Oct. 10 /- CSMG,Techn...ology management,company, announced the company ha...approval is on a key divisional application for "B...Frequency Electric Current,Therethrough" for CSMG ..."),platform tissue bonding/welding technology. The...
(Date:10/10/2008)...f., Oct. 10 /- Finesse Solutions, LLC...ons for life science process,applications, is plea...tore,that makes shopping for sensors and transmitt...inesse web site ( http://www.finesse.com/shopfines... sensors and accessories,on-line, anywhere in the ...
Breaking Biology Technology:MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 2MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 3MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 4MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 5Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 3
...bout the latest outrages in the CEO suite, let me ...jority of top executives are honest and good peopl... success. And that the CEO,s I will be talking abo...g. Still, these are people who work the system to ... that can easily lead even the most successful com...
... promote competition. It was supposed to create ce... better infrastructure. Ten years later, can we sa...s wasted? Did we ever really achieve the open comp...esday is the tenth anniversary of the act. Especia... these controversies surrounding competition and t...
...d Software, a Milwaukee-based startup that runs an...eships around the universe. , , Official screensh...Technology Innovation Center that houses many more...s like Shining Brow Software and Niceware Inter...t Vendetta Online , came about in part because of...
...ank of Green Bay have joined a new $125 venture fu..., Tonka Bay Equity Partners of Minnetonka, Minnes...s from around the country and some individual inve...sinesses in manufacturing and business services. ,...roughout Wisconsin, but they,re particularly focus...
Other Biology Technology:What color is your CEO's parachute? 2What color is your CEO's parachute? 3What color is your CEO's parachute? 4Was the Telecom Act of 1996 a boon or bomb for U.S.? 2Was the Telecom Act of 1996 a boon or bomb for U.S.? 3Was the Telecom Act of 1996 a boon or bomb for U.S.? 4Was the Telecom Act of 1996 a boon or bomb for U.S.? 5John Bergman, co-founder of Guild Software 2John Bergman, co-founder of Guild Software 3
(Date:10/12/2008)...elease is also available in French . , Resear...and GlaxoSmithKline Inc. have identified two genet... astounding sevenfold increase the risk of male pa...t. 12 in the journal Nature Genetics. , About ...ldness by age 45. The condition,s social and econo...
(Date:10/12/2008)...ave a built-in weapon against HIV, but until recen... study published online by the journal Nature re...me known as APOBEC-3G and suggests new directions... every human cell. It is capable of stopping HIV a...us transcribes its RNA into viral DNA. , The stu...
(Date:10/10/2008)... for Special Surgery researchers have found that s...n who are suffering from pregnancy complications c...g to a study in mice. In this autoimmune syndrome,...ipids, the main components of cell membranes. This...issue of the Journal of Clinical Investigation t...
(Date:10/10/2008)...chers report on a previously unknown relationship ...f their mitochondria a cell,s energy makers. Stem ...eater capacity to differentiate and are more likel...his week in JBC, could lead to methods of enrichin...eutic use and may provide some insights into the r...
Breaking Biology News(10 mins):Researchers discover baldness gene: 1 in 7 men at risk 2Body's anti-HIV drug explained 2Statins may prevent miscarriages 2Statins may prevent miscarriages 3Toms of Maine Tooth Floss Earns American Dental Associations Seal of Acceptance 1187 1Toms of Maine Tooth Floss Earns American Dental Associations Seal of Acceptance 1187 2J D Power and Associates Reports 3A CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year 1184 1J D Power and Associates Reports 3A CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year 1184 2J D Power and Associates Reports 3A CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year 1184 3Verdict One Releases Directory of Board Certified Attorneys for Consumers 1181 1Verdict One Releases Directory of Board Certified Attorneys for Consumers 1181 2Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion P 562 1Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion P 562 2Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion P 562 3
...nsion in yeast have been identified by researchers...ically reducing calorie intake, or caloric restric...ncluding yeast, worms and rodents. Previous resear...on due to caloric restriction, but worms and yeast...gh diet, showing that some other genes must be at ...
...s nerve cells to trees -- some are short and bushy...ew branches coming out of one or two main trunks. ...ic disorders and Firestein,s quest is to discover ..., A new paper by Firestein and her colleagues at R...es the role of the protein snapin in nerve branch,...
...have found that gene expression in the brain can d...h different life histories. Their study indicates ...how differential expression in males who migrate f...ns versus those who do not leave the freshwater en... University, the University of Massachusetts and t...
...e biological trigger that gives rise to Van Buchem...that can cause blindness and deafness. The finding...and could lead to new treatments for osteoporosis ...eam from Lawrence Livermore and Lawrence Berkeley ... BioMedical Research in Switzerland, and the DOE J...
Other Biology News:Snapin: A protein with therapy potential for autism 2Divergent life history shapes gene expression in brains of salmon 2Researchers track down cause of a disfiguring bone disorder 2Researchers track down cause of a disfiguring bone disorder 3
...madzu Biotech presents PsiPort Mass Directed Auto ... data acquisition system designed for automated co...ence and pharmaceutical discovery programs. The sy...gh throughput mass directed auto purification for ...
The Rapid DNA Ligation Kit enables ligation of sticky-end or blunt-end DNA fragments in just 5 min at 15-25 C. Depending on the DNA concentration, either circular (low DNA concentration) or concatem
Nuclease S7; Micrococcal nuclease from Roche Applied Science
Anti-VDAC (Voltage-Dependent Anion Channel) AVOID FREEZE/THAW CYCLES. Recognizes the porin 31HL protein. Corresponds to mAb 1 in the literature.
Biology Products: